Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAP)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / Ordinary Shares, par value GBP 0.001 per share
Number of holders
77
Total Shares
124M
Shares change
-27.4M
Total reported value, excl. options
$67M
Value change
-$30.5M
Put/Call ratio
0.48
Number of buys
26
Number of sells
-35
Price
$0.54
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.